@article {Wisniak2021.07.05.21260024, author = {Ania Wisniak and H{\'e}l{\`e}ne Baysson and Nick Pullen and Mayssam Nehme and Francesco Pennacchio and Mar{\'\i}a-Eugenia Zaballa and Idris Guessous and Silvia Stringhini}, title = {COVID-19 Vaccination acceptance in the canton of Geneva: A Cross-Sectional Population-Based Study}, elocation-id = {2021.07.05.21260024}, year = {2021}, doi = {10.1101/2021.07.05.21260024}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Objective This study aimed to assess acceptance of COVID-19 vaccination as well as its sociodemographic and clinical determinants in a general population sample three months after the launch of the vaccination program in Switzerland.Methods In March 2021, an online questionnaire on vaccination acceptance was proposed to adults included in a longitudinal cohort study of previous population-based serosurveys carried out in the canton of Geneva. Questions were asked about COVID-19 vaccination acceptance, reasons of acceptance or refusal, and attitudes about vaccination in general. Data on demographic (age, sex, education, income, professional status, living conditions) and health-related characteristics (having a chronic disease, COVID-19 diagnosis, smoking status) were assessed at inclusion in the cohort (December 2020).Results Overall, 4{\textquoteright}067 participants (completion rate of 77.4\%) responded to the survey between March 17 and April 1, 2021. The mean age of respondents was 53.3 years and 56.0\% were women. Most had completed tertiary education (64.7\%) and over 60\% were currently professionally active. At the time of the survey, 17.2\% of respondents had already been vaccinated with at least one dose or had made an appointment to get vaccinated, and an additional 58.5\% intended or rather intended to get vaccinated. The overall acceptance of COVID-19 vaccination was 75.7\%, with a higher acceptance among men compared to women, older adults compared to younger adults, high-income individuals compared to those with a low income, participants living in urban and semi-urban areas compared to rural, and retirees and students compared to employed individuals. Acceptance was lower among individuals having completed apprenticeships and secondary education compared to those with tertiary education. The most common reasons reported by participants intending to get vaccinated were the desire to {\textquoteleft}get back to normal{\textquoteright}, to protect themselves, their community and/or society, and their relatives or friends against the risk of infection by SARS-CoV-2, as well as the desire to travel. Less than half (45.6\%) of participants having children were willing or rather willing to have their children vaccinated against COVID-19 if it were recommended by public health authorities.Conclusion Although our study found a 75.7\% acceptance of COVID-19 vaccination, there were noticeable socio-demographic disparities in vaccination acceptance. These data will be useful for public health measures targeting hesitant populations when developing health communication strategies. These results will be updated over time with a new release of the survey in autumn 2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Swiss Federal Office of Public Health, the General Directorate of Health of the Department of Safety, Employment and Health of the canton of Geneva, the Private Foundation of the Geneva University Hospitals, the Swiss School of Public Health (Corona Immunitas Research Program) and the Fondation des Grangettes.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the Cantonal Research Ethics Commission of Geneva, Switzerland (project number 2020-00881).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used within this study is made available upon reasonable request to the last author.}, URL = {https://www.medrxiv.org/content/early/2021/07/06/2021.07.05.21260024}, eprint = {https://www.medrxiv.org/content/early/2021/07/06/2021.07.05.21260024.full.pdf}, journal = {medRxiv} }